Role of VHL Gene Mutation in Human Cancer
Howard Hughes Medical Institute · Dana-Farber Brigham Cancer Center
Abstract
Germline inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene causes the von Hippel-Lindau hereditary cancer syndrome, and somatic mutations of this gene have been linked to the development of sporadic hemangioblastomas and clear-cell renal carcinomas. The VHL tumor suppressor protein (pVHL), through its oxygen-dependent polyubiquitylation of hypoxia-inducible factor (HIF), plays a central role in the mammalian oxygen-sensing pathway. This interaction between pVHL and HIF is governed by post-translational prolyl hydroxylation of HIF in the presence of oxygen by a conserved family of Egl-nine (EGLN) enzymes. In the absence of pVHL, HIF becomes stabilized and is free to induce the expression of its…
Citation impact
- FWCI
- 21.74
- Percentile
- 100%
- References
- 181
Authors
2Topics & keywords
- Cancer research
- Angiogenesis
- Somatic cell
- Hypoxia-inducible factors
- Germline mutation
- Tumor suppressor gene
- Germline
- Biology
- Good health and well-being